Activist 13D/13G Filings - Venrock Healthcare Capital Partners II L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-14
8:56 pm
Purchase
13GDBV Technologies S.A.
DBVT
Venrock Healthcare Capital Partners II L.P.9,654,656
9.99%
251,177increase
(+2.67%)
View
2024-02-14
8:47 pm
Purchase
13GTrevi Therapeutics Inc.
TRVI
Venrock Healthcare Capital Partners II L.P.6,707,564
9.99%
395,372increase
(+6.26%)
View
2024-02-14
8:46 pm
Sale
13GAnnexon Inc.
ANNX
Venrock Healthcare Capital Partners II L.P.968,679
1.2%
-3,960,321decrease
(-80.35%)
View
2024-02-14
8:35 pm
Sale
13GSAVARA INC
SVRA
Venrock Healthcare Capital Partners II L.P.3,500,000
2.6%
-2,851,531decrease
(-44.90%)
View
2024-02-14
8:35 pm
Purchase
13GLyra Therapeutics Inc.
LYRA
Venrock Healthcare Capital Partners II L.P.5,553,552
9.999%
2,120,284increase
(+61.76%)
View
2024-02-14
8:34 pm
Sale
13GGH RESH PLC SHS
GHRS
Venrock Healthcare Capital Partners II L.P.1,318,327
2.5%
-2,198,798decrease
(-62.52%)
View
2024-02-14
8:34 pm
Sale
13GINOZYME PHARMA INC
INZY
Venrock Healthcare Capital Partners II L.P.0
0%
-3,867,749decrease
(Position Closed)
View
2024-02-14
8:33 pm
Purchase
13GCogent Biosciences Inc.
COGT
Venrock Healthcare Capital Partners II L.P.9,038,844
9.99%
1,729,716increase
(+23.67%)
View
2024-02-14
8:32 pm
Sale
13GAclaris Therapeutics Inc.
ACRS
Venrock Healthcare Capital Partners II L.P.0
0%
-4,563,962decrease
(Position Closed)
View
2023-02-14
5:11 pm
Sale
13GAxsome Therapeutics Inc.
AXSM
Venrock Healthcare Capital Partners II L.P.0
0%
-2,333,975decrease
(Position Closed)
View
2023-02-14
4:55 pm
Purchase
13GTrevi Therapeutics Inc.
TRVI
Venrock Healthcare Capital Partners II L.P.6,312,192
9.99%
2,643,858increase
(+72.07%)
View
2023-02-14
4:55 pm
Purchase
13GCogent Biosciences Inc.
COGT
Venrock Healthcare Capital Partners II L.P.7,309,128
9.99%
3,007,002increase
(+69.90%)
View
2023-02-14
4:40 pm
Purchase
13GLyra Therapeutics Inc.
LYRA
Venrock Healthcare Capital Partners II L.P.3,433,268
9.999%
218increase
(+0.01%)
View
2023-02-14
4:31 pm
Purchase
13GDBV Technologies S.A.
DBVT
Venrock Healthcare Capital Partners II L.P.9,403,479
9.99%
651increase
(+0.01%)
View
2023-02-14
4:13 pm
Sale
13GLIANBIO SPONSORED ADS
LIANY
Venrock Healthcare Capital Partners II L.P.4,793,047
4.4%
-585,294decrease
(-10.88%)
View
2023-02-14
4:09 pm
Sale
13GINOZYME PHARMA INC
INZY
Venrock Healthcare Capital Partners II L.P.3,867,749
9.3%
-197,251decrease
(-4.85%)
View
2023-02-14
4:08 pm
Sale
13GProvention Bio Inc.
PRVB
Venrock Healthcare Capital Partners II L.P.1,118,653
1.3%
-2,725,143decrease
(-70.90%)
View
2023-02-14
4:07 pm
Sale
13GMARINUS PHARMACEUTICALS INC
MRNS
Venrock Healthcare Capital Partners II L.P.1,770,705
3.7%
-1,109,391decrease
(-38.52%)
View
2023-02-14
4:07 pm
Purchase
13GAnnexon Inc.
ANNX
Venrock Healthcare Capital Partners II L.P.4,929,000
9.99%
3,000,523increase
(+155.59%)
View
2023-02-14
4:07 pm
Purchase
13GGH RESH PLC SHS
GHRS
Venrock Healthcare Capital Partners II L.P.3,517,125
6.8%
696,624increase
(+24.70%)
View
Goto 0, 1, 2, 3, Next